Relationship between colonic polyp type and the neutrophil/lymphocyte ratio as a biomarker

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 3159-3161

  Karaman, Hatice ^a   Karaman, Ahmet ^a   Erden, Abdulsamet ^a   Poyrazoglu, Orhan Kursat ^a   Karakukcu, Cigdem ^a   Tasdemir, Arzu ^a  

^a Kayseri Education and Research Hospital ^*  (Turkey)

Author keywords

Colon polyps; Neoplastic polyps; Neutrophil to lymphocyte ratio

Indexed keywords

TUMOR MARKER;

ADENOMA; ARTICLE; CANCER STAGING; COLON POLYP; COLON TUMOR; HUMAN; HYPERPLASIA; INFLAMMATION; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PROGNOSIS;

ADENOMA; COLONIC NEOPLASMS; COLONIC POLYPS; HUMANS; HYPERPLASIA; INFLAMMATION; LYMPHOCYTES; MIDDLE AGED; NEOPLASM STAGING; NEUTROPHILS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84880339828     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.3159     Document Type: Article

References (19)

1. Al-Shaiba R, McMillan DC, Angerson WJ, et al (2004). The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases. Br J Cancer, 91, 205-7.
2. An X, Ding PR, Li YH, et al (2010). Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers, 15, 516-22.
3. Cho H, Hur HW, Kim SW et al (2008). Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother, 58, 15-23.
4. Chua W, Charles KA, Baracos VE, et al (2011). Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer, 104, 1288-95.
5. Correa P (1979). Epidemiology of polyps and cancer in the human intestine. Gastroenterology, 77, 1245-51.
6. Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7.
7. Fenoglio CM, Pascal RR (1982). Colorectal adenomas and cancer: Pathologic relationships. Cancer, 50, 2601-8.
8. Halazun KJ, Aldoori A, Malik HZ, et al (2008). Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol, 34, 55-60.
9. Imtiaz F, Shafique K, Mirza SS et al (2012). Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Archives of Med. 5, 2.
10. Ishizuka M, Nagata H, Takagi K, et al (2012). C-reactive protein is associated with distant metastasis of T3 colorectal cancer. Anticancer Res, 32, 1409-15.
11. Konishi F, Morson BC (1982). Pathology of colorectal adenomas: A colonoscopic survey. J Clin Pathol, 35, 830-41.
12. Linton A, Zandwijk N, Reid G, Stephen Clarke et al (2012). Inflammation in malignant mesothelioma - friend or foe?. Ann Cardiothorasic Surg, 1, 516-22.
13. Mc Millan DC, Canna K, Mc Ardle CS (2003). Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg, 90, 215-9.
14. Morson BC (1966). Factors influencing the prognosis of early cancer of the rectum. Proc R Soc Med, 59, 607-8.
15. Pages F, Berger A, Camus M, et al (2005). Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med, 353, 2654-66.
16. Saito K, Kihara K (2010). Role of C-reactive protein as a biomarker for renal cell carcinoma. Expert Rev Anticancer Ther, 10, 1979-89
17. Ubukata H, Motohashi G, Tabuchi T, et al (2010). Evaluations of interferon-?/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol, 102, 742-7.
18. Ueno H, Hawrylowicz CM, Banchereau J (2007). Immunological intervention in human diseases. J Transl Med, 5, 59.
19. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005). Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol, 91, 181-4